India  
 
NewsR.in

FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 Years

Video Credit: WBZ CBS Boston - Duration: 02:26s - Published
FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 Years

FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 Years

The FDA approved the first new drug for Alzheimer’s disease in nearly 20 years Monday, even though the decision to greenlight Biogen’s new drug has been fraught with controversy.

WBZ-TV's Mallika Marshall has more.


You Might Like


Related videos from verified sources

Your Healthy Family: New Therapy Brings Hope to Man Fighting Alzheimer's [Video]

Your Healthy Family: New Therapy Brings Hope to Man Fighting Alzheimer's

The new drug targets amyloid, a protein that forms in the brain creating plaques, which are believed to cause dementia.

Credit: KOAA - Southern Colorado     Duration: 02:26Published
New rules make it easier for FDA to crack down on unscrupulous stem cell providers, doctors hope [Video]

New rules make it easier for FDA to crack down on unscrupulous stem cell providers, doctors hope

New FDA rules aim to crack down on false and misleading claims by businesses trying to sell unproven, unregulated stem cell therapies. Investigative Reporter Katie LaGrone explains.

Credit: WPTV News | West Palm Beach     Duration: 02:54Published
Groundbreaking Yet Controversial Alzheimer’s Drug Administered to First Patient [Video]

Groundbreaking Yet Controversial Alzheimer’s Drug Administered to First Patient

It could be a game-changer for treating Alzheimer’s, but not all are convinced. Veuer’s Tony Spitz has the details.

Credit: Veuer     Duration: 01:04Published